Market Closed

ARVN
Arvinas
$ 6.82
-0.73%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Arvinas News

Latest Arvinas Stock News & ARVN Headlines

Arvinas to Present at Jefferies Global Healthcare Conference
5 days ago | globenewswire.com
What Arvinas (ARVN) Said on Its Q3 Earnings Call
11 days ago | defenseworld.net
Arvinas to Present Preliminary Clinical Data from Early Monotherapy Dose Escalation Cohorts in the Phase 1 Trial for ARV-393 (Zaloblideg), a PROTAC BCL6 Degrader, at the 2026 American Society of Hematology (ASH®) Annual Meeting
11 days ago | globenewswire.com
Arvinas, Inc. (ARVN) Q3 2026 Earnings Call Transcript
12 days ago | seekingalpha.com
What Arvinas (ARVN) Said on Its Q3 Earnings Call
13 days ago | marketbeat.com
Arvinas, Inc. (ARVN) Reports Q3 Loss, Misses Revenue Estimates
13 days ago | zacks.com
Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update
13 days ago | globenewswire.com
Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
19 days ago | globenewswire.com
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
20 days ago | globenewswire.com
Reasons Why Investors Should Consider Betting on Arvinas Stock
a month ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ARVN
Arvinas
$ 6.82
-0.73%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago